Work

US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer

Year: 2023

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.23.00615

Authors: Melanie Royce, Flora Mulkey, Christy Osgood, Erik Bloomquist, Laleh Amiri-Kordestani

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367173134

FWCI: 2.372

Cites: 2

Cited by: 15

Related to: 10